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Diphtheria toxoid is produced by detoxiﬁcation of diphtheria toxin with formaldehyde. This study was
performed to elucidate the chemical nature and location of formaldehyde-induced modiﬁcations in
diphtheria toxoid. Diphtheria toxin was chemically modiﬁed using 4 different reactions with the
following reagents: (1) formaldehyde and NaCNBH3, (2) formaldehyde, (3) formaldehyde and NaCNBH3
followed by formaldehyde and glycine, and (4) formaldehyde and glycine. The modiﬁcations were
studied by SDS-PAGE, primary amino group determination, and liquid chromatographyeelectrospray
mass spectrometry of chymotryptic digests. Reaction 1 resulted in quantitative dimethylation of all
lysine residues. Reaction 2 caused intramolecular cross-links, including the NADþ-binding cavity and the
receptor-binding site. Moreover, A fragments and B fragments were cross-linked by formaldehyde on
part of the diphtheria toxoid molecules. Reaction 3 resulted in formaldehyde-glycine attachments,
including in shielded areas of the protein. The detoxiﬁcation reaction typically used for vaccine prepa-
ration (reaction 4) resulted in a combination of intramolecular cross-links and formaldehyde-glycine
attachments. Both the NADþ-binding cavity and the receptor-binding site of diphtheria toxin were
chemically modiﬁed. Although CD4þ T-cell epitopes were affected to some extent, one universal CD4þ T-
cell epitope remained almost completely unaltered by the treatment with formaldehyde and glycine.
© 2020 The Authors. Published by Elsevier Inc. on behalf of the American Pharmacists Association®. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Introduction
Diphtheria and tetanus toxoids are veryeffective vaccine antigens,
virtually eliminating associated diseases in vaccinated populations.
Many countries have included these vaccines in their national im-
munization programs, which has drastically reduced the incidence
and severity of diphtheria and tetanus.1 Currently, a dozen companies, Tandem liquid chromatog-
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Inc. on behalf of the American Phaaround the world are producing diphtheria and tetanus vaccines.
These toxoid vaccines were developed almost a century ago.2-4 As a
result, extensive data sets have been collected by companies and
ofﬁcial medicines control laboratories to assure the quality of suc-
cessive vaccine lots.5,6 Much experience with toxoid vaccines has
been acquired by using the traditional potency and safety tests in
animals. However, although the formaldehyde-induced chemical
modiﬁcations of the antigen largely determine the quality of toxoid
vaccines, little is known about the molecular structure of toxoids.
Interest has arisen in structural characterization of diphtheria,
tetanus, and Clostridium difﬁcile toxins7-12 and toxoids.13-26 Three
reasons for this increased attention can be deduced from the
literature, including (1) the development of analytical tests for
quality control of toxoid-containing vaccines, (2) the development
of advanced vaccine formulations for toxoid vaccines and (3) the
use of toxoids as carrier proteins in conjugate vaccines:rmacists Association®. This is an open access article under the CC BY-NC-ND license
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Scheme 1. The reaction of formaldehyde with proteins. The reaction starts with the
formation of methylol adducts on amino groups [1]. The methylol adducts of primary
amino groups are partially dehydrated, yielding labile Schiff bases [2], which can form
cross-links with 6 different amino acid residues, for example, with tyrosine [3] and
arginine [4].
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developed to assess the quality of toxoid-containing
vaccines.16,18,19,21,23,25,27-37 These tests are valuable for ex-
amination of the purity, safety, potency, and stability of a
product to reveal the impact of changes in a production
process.38,39
(2) Furthermore, the development of innovative vaccine formu-
lations with diphtheria and tetanus toxoids has demanded
detailed structural characterization of the toxoids.24,26,40-43
For example, controlled release or oral formulations with
tetanus toxoid were designed by using polyester or chitosan
microspheres.20,42,44-47 Often, antigen instability in new
vaccine delivery systems has been observed.15,48-50
(3) A third reason for renewed interest is the use of tetanus
toxoid, diphtheria toxoid, and a mutant of diphtheria toxoid
(CRM197) as carrier proteins in the production of poly-
saccharide conjugate vaccines. Multiple conjugate vaccines
are available on the market.51 Furthermore, several new
conjugate vaccines are under development, for example,
vaccines against Shigella ﬂexneri and Salmonella typhi.52,53
Altogether, insight into the molecular structure of toxoids may
help to improve the quality control of vaccines, support rational
development of advanced vaccine formulations, and facilitate the
development of new conjugate vaccines.
Formaldehyde-mediated detoxiﬁcation is an important step in
the production of toxoid vaccines. To initiate the detoxiﬁcation
process, formaldehyde and extra glycine are usually added to
diphtheria toxinecontaining culture supernatant, which contains
amino acids and metabolites. Formaldehyde treatment changes the
toxicity, antigenicity, and immunogenicity of diphtheria and
tetanus toxoid.16,18,54 Formaldehyde treatment causes chemical
modiﬁcations in toxoid molecules. Remarkably, the chemical na-
ture of each speciﬁc modiﬁcation and the exact locations of the
modiﬁed residues within diphtheria toxoid molecules have not yet
been identiﬁed. For diphtheria toxin, formaldehyde converts the
protein into a nontoxic toxoid, probably by permanently altering
critical domains in the protein, for example, the catalytic site
(NADþ-binding cavity) and the receptor-binding site. Although
detoxiﬁcation causes the loss of some B-cell epitopes, the toxoid
remains very immunogenic and induces a protective immune
response by the generation of toxin-neutralizing antibodies.16
The reaction of formaldehyde with a protein starts with the
formation of reversible methylol adducts on amino groups (Scheme
1). The methylol groups are partially dehydrated, yielding labile
Schiff-bases. These Schiff-bases generate intramolecular cross-links
with accessible, reactive amino acid residues, including arginine,
asparagine, glutamine, histidine, tryptophan, and tyrosine.
Furthermore, formaldehyde can attach amino acids in solution to
these reactive amino acid residues.55 The conversion of reactive
amino acid residues depends on their intrinsic reactivity and their
accessibility for formaldehyde.55,56
The aim of the present study was to elucidate the chemical
modiﬁcations in diphtheria toxoid as a result of the detoxiﬁcation
by formaldehyde and glycine. We investigated the reactivity of the
individual lysine residues with formaldehyde, the formation of
intramolecular cross-links and the attachment of formaldehyde-
glycine moieties in diphtheria toxoid. Special emphasis was put
on modiﬁcations in crucial parts of the molecule, that is, the cata-
lytic site (NADþ-binding cavity), the receptor-binding site, and
CD4þ T-cell epitope regions. The NADþ-binding cavity is located in
the catalytic domain of diphtheria toxin that transfers the ADP-
ribose moiety of NADþ to elongation factor-2.57 The modiﬁcation
of elongation factor-2 irreversibly inhibits the protein synthesis inthe host cell leading to cell death. Three short peptide sequences in
the diphtheria toxinmolecule form the NADþ-binding cavity, a loop
from the residues 17-23, a b-strand followed by an a-helix from
residues 50-67, and a b-strand from residues 147-150 (Fig. 1a).
Amino acid residues His21, Tyr54, Tyr65, and Glu148 participate in the
binding of NADþ.58,59 Another important area in the toxin molecule
is the receptor-binding site, which is formed by a loop of amino acid
residues 511-530. This part of the receptor domain binds to the
heparin-binding epidermal growth factor-like precursor.60,61 The
residues Tyr514, Lys516, Val523, Asn524, Lys526, and Phe530 participate
in binding to the host cell receptor.60 The crystal structure of the
receptor-bound diphtheria toxin complex is elucidated (Fig. 1b).62
In addition, CD4þ T-cell epitopes are identiﬁed by using blood
from healthy subjects.63 The CD4þ T-cell epitopes are located in the
B-fragment of diphtheria toxin: a-helices formed by residues 271-
290, 321-340, and 331-350.
The NADþ-binding cavity, the receptor-binding site, and CD4þ
T-cell epitopes contain formaldehyde reactive residues. The
formaldehyde-induced modiﬁcations in NADþ-binding cavity and
the receptor-binding site of diphtheria toxin probably are
responsible for complete detoxiﬁcation. However, modiﬁcations
in CD4þ T-cell epitope regions of diphtheria toxin might reduce
the immunogenicity of diphtheria vaccines. The chemical modi-
ﬁcations in diphtheria toxin were analyzed by SDS-PAGE, primary
amino group determination (TNBS assay) and liquid
chromatographyeelectrospray mass spectrometry (LC-MS) after
digestion with chymotrypsin. In this study, we revealed the
location and chemical nature of modiﬁcations that occur in
diphtheria toxoid during a detoxiﬁcation process by formaldehyde
and glycine.
Figure 1. Catalytic and receptor binding sites in diphtheria toxin. The images represent 2 functional sites in diphtheria toxin: (a) the catalytic site (NADþ-binding cavity; PDB: 1TOX)
and (b) the receptor-binding site (PDB: 1XDT) interacting with the binding site of the cell-surface receptor (HB-EGF). Searching for PDB codes was performed on https://www.rcsb.
org/. The side chains are shown of those amino acid residues of diphtheria toxin that are potentially reactive with formaldehyde.55
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Chemicals
Formaldehyde (37%) (CH2O), formaldehyde-D2 (20%), (CD2O),
glycine, sodium cyanoborohydride (NaCNBH3), sodium bisulphite,
triethyl ammonium bicarbonate buffer pH 8.5, and dimethyl sulf-
oxide were obtained from Sigma-Aldrich (Schnelldorf, Germany).
Formic acid (99%), sodium dihydrogen phosphate (NaH2PO4),
disodium hydrogen phosphate (Na2HPO4), and sodium chloride
were purchased from Merck (Darmstadt, Germany). Water was
purchased from Biosolve Chimie SARL (Dieuze, France). Chymo-
trypsin was bought from Roche Diagnostics (Mannheim, Germany)
and acetonitrile from Biosolve (Valkenswaard, the Netherlands).
Chemical Treatment of Diphtheria Toxin
Before detoxiﬁcation reactions, diphtheria toxinecontaining
culture supernatant (Intravacc, the Netherlands) was dialyzed
(MWCO 10 kDa; Slide-A-Lyzer Dialysis Cassette; Thermo Scientiﬁc;
Rockford, IL) extensively against PBS (0.15MNaCl, 7.7 mMNa2HPO4
and 2.3 mM NaH2PO4, pH 7.2). Aqueous solutions of formaldehyde
(CH2O), deuterium-labeled formaldehyde (CD2O), glycine, and
NaCNBH3 were prepared at a concentration of 1.0 M in water. Four
reactions (Fig. 2) with diphtheria toxin were performed: (reaction
1) diphtheria toxin with formaldehyde and NaCNBH3, (reaction 2)
diphtheria toxin with formaldehyde (CH2O or CD2O), (reaction 3)
diphtheria toxin with formaldehyde (CH2O or CD2O) and glycine,
(reaction 4) diphtheria toxin with formaldehyde (CH2O) and
NaCNBH3 followed by the reaction with formaldehyde (CH2O or
CD2O) and glycine. The composition and conditions for reaction 2
are comparable to those used for vaccine production.16
Reaction 1
Formaldehyde (CH2O) and NaCNBH3 were added to diphtheria
toxin (1.2 mg/mL) to ﬁnal concentrations of 50 mM. After mixing,
the solution was incubated for 2 h at 35C. Then, the sample was
extensively dialyzed against 10 mM PBS pH 7.2 (MWCO 10 kDa).
Reaction 2
Formaldehyde (CH2O or CD2O) was added to diphtheria toxin
(1.2 mg/mL) to ﬁnal concentrations of 80 mM. After mixing, the
solutions were incubated for 1 week at 37C. Then, the reactionwas
stopped by adding sodium bisulphite to a ﬁnal concentration of 80
mM and subsequently extensively dialyzed against PBS (MWCO 10kDa). Sodium bisulphite reacted with free formaldehyde in solution
(Na2HSO3 þ CH2O # HOCH2SO3Na). As a result, the reversible
methylol groups and Schiff bases on diphtheria toxoid were largely
removed because the equilibrium shifted to the left (protein-NH2 þ
CH2O# protein-NHCH2OH# protein-NHCH2 þ H2O).Reaction 3
Diphtheria toxin (1.2 mg/mL) was incubated for 2 h at 37C with
formaldehyde (CH2O) and sodium cyanoborohydride. The ﬁnal
concentrations of formaldehyde and sodium cyanoborohydride in
the samples were 50 mM. The sample was extensively dialyzed
against PBS. The obtained dimethylated diphtheria toxin was
incubated for 1 week at 37C with formaldehyde (CH2O or CD2O)
and glycine. The ﬁnal concentrations of formaldehyde and glycine
in the samples were 80 mM and the concentration of diphtheria
toxin was 1.2 mg/mL. After the incubation, sodium bisulphite was
added to a ﬁnal concentration of 80 mM. Samples were extensively
dialyzed against PBS (MWCO 10 kDa).Reaction 4
Diphtheria toxin (1.2 mg/mL) was incubated for 1 week at 37C
with formaldehyde (CH2O or CD2O) and glycine. The ﬁnal concen-
trations of formaldehyde and glycine in the samples were 80 mM.
The reaction was stopped by adding sodium bisulphite to a ﬁnal
concentration of 80 mM. Both samples were extensively dialyzed
against PBS (MWCO 10 kDa).
Finally, all samples were stored at 4C before analysis by SDS-
PAGE, TNBS assay, and LC-MS.SDS-PAGE
SDS-PAGE was performed under reducing conditions, essen-
tially as described by Sambrook et al.64 Protein samples were pre-
pared bymixing 2 mg of the toxoid in the sample buffer (60mMTris,
70 mM SDS, 0.1 M dithiothreitol, 0.1 mM tetrabromophenol blue
and 35% glycerol diluted in water) to a volume of 20 mL, and boiled
for 10min to denature the protein and to reduce disulphide bridges.
The samples were loaded onto 12% SDS-PAGE gels and electro-
phoretically separated. Molecular weight reference (broad range;
Bio-Rad) was used for calibration. Protein bands were visualized by
using Imperial Protein Stain (Pierce). The gels were scanned, and
the intensity of protein bands was quantiﬁed using ImageJ 1.46r
software (NIH).
Figure 2. Characterization of formaldehyde-induced modiﬁcations in diphtheria toxoid by using stable isotope labeling strategies. Reaction 1: The accessibility of the lysine residues
in diphtheria toxin after reductive dimethylation and digestion was determined by LC-MS/MS and database search analysis. Reaction 2: Target identiﬁcation of cross-links in
diphtheria toxoid formed on formaldehyde treatment. Treatment with light (CH2O) and heavy (CD2O) formaldehyde resulted in intramolecular cross-links that appear as mass
spectral doublets, whereas unmodiﬁed peptides appear as singlets. After digestion, the formaldehyde-modiﬁed peptides contain a cross-link within the peptide (intrapeptide cross-
link) or between 2 peptides (interpeptide cross-link). Reaction 3: Identiﬁcation of modiﬁed residues by glycine attachments. First, lysine residues were blocked to prevent
intrapeptide and interpeptide cross-linking. As a result of treatment with light (CH2O) or heavy (CD2O) formaldehyde and glycine, chemically modiﬁed peptides appear as mass
spectral doublets, whereas unmodiﬁed peptides appear as singlets. Reaction 4: The standard detoxiﬁcation of diphtheria toxin. The protein is treated with light (CH2O) or heavy
(CD2O) formaldehyde and glycine, resulting in the differential labeling of both formaldehyde-induced cross-links and formaldehyde-glycine attachments.
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The protein concentration of dialyzed diphtheria toxin or toxoid
samples was determined by using the BCA protein assay according
to the manufacturer's description (Thermo Fisher Scientiﬁc, the
Netherlands).
TNBS Assay
The concentration of primary amino groups present in diph-
theria toxin or toxoid samples was determined by using a colori-
metric assay with 2,4,6-trinitrobenzene sulfonic acid (TNBS).65 A
reference (10-100 mM) was prepared from a stock solution of 1.0
mM glycine. The number of primary amino groups in a diphtheria
toxin or toxoid molecule was calculated; primary amino groups
(mM)/protein concentration (mM). The molecular mass of 58.3 kDa
for the diphtheria toxin was used for the calculation.
Digestion by Chymotrypsin
Diphtheria toxin and toxoids (from reaction 1, 2, 3, and 4) were
individually digested by chymotrypsin (diphtheria toxin was used
as a control.) To that end, 5 mL of a 1-M triethyl ammoniumbicarbonate buffer, pH 8.5, and 2 mL of 1.0 mg/mL chymotrypsin
were added to each sample containing 0.1 mg toxin or toxoid.
Water was added to a ﬁnal volume of 100 mL. Samples were incu-
bated for 16 h at 37C. Subsequently, the samples were stored
at 20C before LC-MS analysis.Liquid ChromatographyeElectrospray Mass Spectrometry
Protein digests were analyzed by nanoscale reversed-phase LC-
MS, essentially as previously described by Meiring et al.,66 using an
Orbitrap Fusion Lumos mass spectrometer (Thermo Scientiﬁc). The
digests of reaction products 1, 2, 3, and 4 were mixed in equal
amounts and diluted in water containing 5% (v/v) dimethyl sulf-
oxide and 0.1% (v/v) formic acid to a concentration corresponding
to 1.0 mMof the original protein concentration. An injection volume
of 10 mL was used for analysis. Analytes were loaded on a trapping
column (Reprosil-Pur C18-AQ 5 mm, Dr. Maisch GmbH, Germany; 20
mm long  100 mm inner diameter) with solvent A (0.1% (v/v)
formic acid in water) in 10 min at 5 mL/min. The analytes were
separated by reversed-phase chromatography on an analytical
column (Reprosil-Pur C18-AQ 3 mm, Dr. Maisch GmbH, Germany;
27.5 cm long  50 mm inner diameter) at a ﬂow rate of 125 nL/min.
A gradient was started with solvent B (0.1% (v/v) formic acid in
0 1 2 3 4
Intact DT         58 kDa
B-fragment      37 kDa
A-fragment      21 kDa
Figure 3. SDS-PAGE of diphtheria toxin (lane 0) and 4 experimental toxoids. The
diphtheria toxoids were prepared by reaction 1 (lane 1), reaction 2 (lane 2), reaction 3
(lane 3), and reaction 4 (lane 4) (see Materials and Methods section for details).
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gradient, the columns were equilibrated in 100% solvent A for
10 min at 125 nL/min. The peptides were measured by data-
dependent acquisition, comprising a MS scan (m/z 300-1500) in
the Orbitrap with a resolution of 120,000 (FWHM), followed by
collision-induced dissociation (CID; ion trap) at top speed with a
cycle time of 3 s. The threshold value for these precursor ions was
set at 25,000 counts. The normalized collision energy was set at
35%, the isolationwidth at 1.6 Da, and the activation Q to 0.250. The
maximum ion injection time for MS scans was set to 50 ms and for
MS/MS scans to 150 ms. Precursor ions with þ2 toþ5 charge states
were selected for MS/MS analysis. Dynamic exclusion was enabled
(exclusion list with 500 entries) with repeat set to 1 and an
exclusion duration of 45 s. The electron-transfer dissociation (ETD)
reagent cation (202.0777) was used for internal mass calibration.
Peptides containing formaldehyde modiﬁcations typically
appeared as mass spectral doublets as a result of the use of ”light”
(CH2O) and ”heavy” (CD2O) formaldehyde. The doublets were
retrieved from the mass spectra by using the software program
MsXelerator (MsMetrix, Maarssen, the Netherlands). Samples were
measured in triplicate. Doublets that were found with a relative
intensity of 105 arbitrary units and present in at least 2 of the 3
replicates were selected for further evaluation. The obtained
doublet lists were exported to text ﬁles and used as parent mass
lists for targeted ETD and CID fragmentation. For ETD fragmenta-
tion, charge stateedependent ETD parameters were used, and for
CID fragmentation, the same settings were used as described pre-
viously. Identiﬁcation of the MS/MS spectra was performed with
PEAKS Studio 8.5 (Bioinformatics Solutions, Waterloo, ON, Canada)
against the Corynebacterium diphtheriae proteome (taxonomic
identiﬁer 257,309, 2267 entries) with the earlier-described form-
aldehyde modiﬁcations55 as variable modiﬁcations. Mass spectra
that were not automatically assigned to modiﬁed peptides were
manually evaluated based on the observed mass and the number of
incorporated formaldehyde molecules.
In Silico Calculation of the Solvent Accessible Surface Area
The in-silico calculation of the solvent accessible surface area
requires knowledge on the solvent radius and assumes that the
solvent molecules are spheres. As such, the connolly molecular area
1 of the solvent molecule in Chem 3D Pro v11.0 was determined
followed by rearranging the equation for the area of a sphere:
rsolvent¼
1
2
ﬃﬃﬃ
A
p
r
(1)
where A is the connolly molecular area and rsolvent is the molecular
solvent radius. As presented in Supplementary Table 1, the value for
rsolvent depended on the type of modiﬁcation performed.
The solvent accessible surface area of monomeric diphtheria
toxin (open form, PDB code: 1TOX67) was calculated by using
the surface area per residue computation (relative solvent
accessibility) in Pymol v. 2.1.1 (Schrodinger LLC) by setting the sol-
vent radius to the values corresponding to formaldehyde or
methylene-modiﬁed glycine (Supplementary Table 1). The gener-
ated residueeaccessibility listwas then exported to GraphPad Prism
in which the plots were generated.
A solvent accessibility surface area calculation was also per-
formed on the diphtheria toxin modiﬁed via N,N-dimethylation at
the ε-amine group of all lysine residues (reaction 1). This was done
by introducing the N,N-dimethylation of 1TOX PDB using the PyTM
python script.68 After this modiﬁcation, the surface accessibility
surface area was calculated by using formaldehyde as solvent, as
described previously.Secondary Structure Information
The secondary structure information added to the plots is based
on the crystal structure of diphtheria toxin (PDB code 1TOX67).Results and Discussion
Production of Diphtheria Toxin and Toxoid
Diphtheria toxoid is usually prepared by adding formaldehyde
and particular amino acids to the culture supernatant after the
cultivation of Corynebacterium diphtheriae. Besides high concen-
trations of diphtheria toxin, the culture supernatant contains other
proteins produced or secreted by the bacteria. Diphtheria toxin is
synthesized as a single protein but has probably to be nicked into
an A and B fragment to exert full biological activity.69
The dialyzed toxin batch used in this study was examined by
SDS-PAGE andmass spectrometry todetermine its purity. SDS-PAGE
demonstrated that diphtheria toxin used in this study was almost
completely nicked (Fig. 3, lane 0). It showed a tiny band of the intact
toxin at 58Da and intense bands of theA andB fragment at 21 and37
Da, respectively. The purity of the toxinwas quantiﬁed by SDS-PAGE
and appeared to be above 90%. To identify the proteins in the culture
supernatant, chymotrypsin-digested material was analyzed by LC-
MS. Thirty-one different proteins were identiﬁed in the concen-
trated culture supernatant (Supplementary Table 2). Based on the
average responseof the3most intensivepeptides fromeachprotein,
the purity of the diphtheria toxin solution was estimated.70 Ac-
cording to the LC-MS analysis, the culture supernatant contained 93
mole% diphtheria toxin. The contents of other proteins were be-
tween 0.05 and 1.3 mole%. The purity of diphtheria toxin was 96%
based onproteinweight (Supplementary Table 2). This puritywas in
line with the results from SDS-PAGE. The dialyzed culture super-
natant was used to study in detail the chemical modiﬁcations of
diphtheria toxin after formaldehyde treatment.Formaldehyde-Reactive Lysine Residues
The modiﬁcations in diphtheria toxoid after formaldehyde and
glycine treatment consist of intramolecular cross-links and
formaldehyde-glycine attachments. The intramolecular cross-links
occur between a lysine residue and a susceptible amino acid res-
idue, that is, arginine, asparagine, glutamine, histidine, tryptophan,
or tyrosine.55 To determine the accessibility of each individual
lysine residue for formaldehyde, diphtheria toxin was treated with
formaldehyde and NaCNBH3 (reaction 1). In this reaction, the pri-
mary amino groups of lysine and N-terminal residues are converted
to dimethylated structures with a mass increment of 28 Da.71 Intact
diphtheria toxin has 40 primary amino groups, whereas the toxin in
the nicked form has one additional primary amino group.
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Figure 4. Average number of primary amino groups in diphtheria toxin (DTx) and
several experimental toxoids (mean ± S.D.; n ¼ 9). The modiﬁed toxoids were prepared
by reaction 1, 2, 3, and 4 (see Materials and Methods section for details).
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diphtheria toxin (reaction 2) with slightly increased masses when
compared to the untreated toxin as a result of the dimethylation
(Fig. 3, lane 1). Unexpectedly, a fourth protein bandwas observed at
about 20 kDa. This 20-kDa band may represent some alternate
fragmentation and not an impurity, as the diphtheria toxin prepa-
rationwas highly pure (Supplementary Table 2). Another possibility
might be that a formaldehyde-induced cross-link was introduced
that caused a higher electrophoretic mobility due to incomplete
unfolding by SDS-PAGE. However, no detailed information was
collected in this study on the nature of this 20-kDa fragment.
TheTNBSassay showed thepresenceof 29primaryaminogroups
in untreateddiphtheria toxin (Fig. 4),which is less than the expected
value (39 lysine residues and 2 N-termini). Apparently, the other
primary amine groups in diphtheria toxinwere not reached by TNBS
or the ε-amino groups of the lysine residues were slightly less
reactive with TNBS than the a-amino groups of the glycine refer-
ence. Treatment of diphtheria toxin with formaldehyde and
NaCNBH3 (reaction 1) resulted in a drastic reduction (93%) of the
number of primary amino groups (Fig. 4). On average, 2 primary
aminogroupswerepresent indiphtheria toxoid after reaction1. This
suggests that most lysine and N-terminal residues were accessible
and modiﬁed by formaldehyde and NaCNBH3 (reaction 1).
Furthermore, the modiﬁed lysine residues in diphtheria toxoid
were identiﬁed by LC-MS analyses after digestion with chymo-
trypsin. Ninety-ﬁve percent (94.6%) of the total primary sequence
of diphtheria toxin, including the complete NADþ-binding and
receptor-binding sites, was identiﬁed by LC-MS. Dimethylation
(DM ¼ þ28 Da) was observed for all lysine residues present in
diphtheria toxin. The conversion into dimethylated lysine residues,
calculated based on data of the 5 most abundant lysine-containing
peptides, was on average 99.6 ± 0.3%. In conclusion, all lysine res-
idues were accessible for formaldehyde-induced modiﬁcations,
which can lead to cross-links with other reactive amino acid resi-
dues in diphtheria toxin.Intramolecular Cross-Links in Diphtheria Toxin
During vaccine production, diphtheria toxin is usually treated
with formaldehyde in the presence of amino acids. In theory, 142 of
the 535 residues in diphtheria toxin can react with formaldehyde
(N-terminal, Arg, Asn, Gln, His, Lys, Tyr, and Trp residues). Because
many residues are partly converted, diphtheria toxoid may consist
of a plethora of different reaction products. The stable
formaldehyde-induced modiﬁcations can be divided into intra-
molecular cross-links and attachments of amino acids. In this study,
2 distinct reactions were performed to simplify the assignment of
the formaldehyde-induced modiﬁcations in diphtheria toxoid, toinduce either intramolecular cross-links (reaction 2) or
formaldehyde-glycine attachments (reaction 3). In reaction 2,
diphtheria toxin was treated with formaldehyde (CH2O) or with
deuterated formaldehyde (CD2O) to introduce only intramolecular
cross-links in the protein. The formaldehyde-glycine attachments
(reaction 3) are described in the next section Formaldehyde-
Glycine Attachments in Diphtheria Toxoid.
SDS-PAGE (Fig. 3; lane 2) performed with formaldehyde-treated
diphtheria toxoid (reaction 2) showed 4 broadened protein bands
of the apparently intact toxoid (59 kDa), the A-fragment (21 kDa),
and the B-fragment (36 kDa). Although less clear than in lane 1
(Fig. 2), a fourth protein band was observed in lane 2 at about 20
kDa. Furthermore, the protein bands were more spread out in lane
2 than in lane 0. The broad bands indicate that the formaldehyde
treatment resulted in a very heterogeneous product. The broad-
ened protein bands are probably caused by different intramolecular
cross-links present in diphtheria toxoid molecules. Depending on
the actually formed cross-links, diphtheria toxoid molecules were
probably not completely unfolded by sodium dodecyl sulfate.16 As a
result, diphtheria toxoid and the fragments were visualized by SDS-
PAGE as smeared protein bands. Furthermore, intermolecular
cross-linking between toxoid molecules is unlikely, as indicated by
the absence of any clear band larger than 59 kDa. However, the
intensity of the apparently intact toxoid band (59 kDa) increased
signiﬁcantly compared to that of the toxin band (lane 0). This
observation can be explained by the formation of formaldehyde
cross-links between the A-fragment and the B-fragment of diph-
theria toxoid. The A-fragment and the B-fragment of diphtheria
toxoid are in close proximity of each other, making the probability
for formation of intramolecular cross-links by formaldehyde rather
high. Intermolecular cross-links formed with small reactive mole-
cules were not expected, because the toxin was extensively dia-
lyzed against PBS and only formaldehyde was added in reaction 2.
In conclusion, the results deduced from SDS-PAGE indicate that
cross-links mainly occur intramolecularly at these formaldehyde
and protein concentrations (Fig. 3; lane 2).
In addition, the number of primary amino groups in diphtheria
toxoid was drastically reduced after formaldehyde treatment (re-
action 2). The TNBS assay revealed, on average, the presence of 6
primary amino groups in each diphtheria toxoid molecule.
Furthermore, LC-MS analysis was performed on chymotrypsin-
digested mixtures of CH2O-treated and CD2O-treated toxoid. The
use of CH2O versus CD2O provided a method to discriminate
formaldehyde-modiﬁed peptides (mass spectral doublets) from
nonunmodiﬁed ones (mass spectral singlets). The analysis gave a
protein coverage of about 95% for the whole sequence (96% of A-
fragment and 95% of B-fragment). Sixty mass spectral doublets
were observed with at least a relative intensity above 105 arbitrary
units. Most peptides pairs had mass differences of 2 or 4 Da, indi-
cating the presence of 1 or 2 formaldehyde-induced modiﬁcation,
respectively (Supplementary Table 3). One spectral doublet had a
mass difference of 6 Da. Fifty modiﬁed peptide sequences were
assigned based onMS/MS data, their exact masses, and the number
of incorporated formaldehyde molecules. The formaldehyde-
induced modiﬁcations in diphtheria toxoid (reaction 2) are
described thereafter and depicted in Figure 5:4-Imidazolididones
In diphtheria toxoid, formaldehyde converted the N-termini of
the A-fragment and B-fragment into cyclic products (Fig. 5). These
ring structures are also called 4-imidazolididones.55,72,73 The ad-
ducts were revealed in the N-terminal peptides of the A-fragment
(G1ADDVVDSSKSF12) and the B-fragment (S194VGSSL199), resulting
in a mass increment of both peptides (DM ¼ þ12 Da).
Figure 5. The modiﬁcations in diphtheria toxin caused by formaldehyde treatment (reaction 2). (a) indicates the A fragment and (b) the B fragment of diphtheria toxin. The blue line
(y-axis left) indicates the theoretical solvent accessible surface area (accessibility) calculated using the molecular solvent radius of formaldehyde. The modiﬁed and unmodiﬁed
peptides derived from chymotrypsin digestion are indicated with a solid and dotted dark red line, respectively, of which the intensities are plotted (y-axis right). In the case of
overlapping peptides, the intensities are summed for the overlapping amino acid positions. The primary structure is indicated on the x-axis along with the amino acid position
number in increments of 10 residues at the top of each plot. The different amino acid modiﬁcations identiﬁed by MS analysis along with the secondary structure elements derived
from the crystal structure PDB 1TOX. The catalytic site, receptor binding site, and CD4þ T-cell epitope are indicated with purple, black, and green underlines, respectively. The
speciﬁc symbols are present in the ﬁgure legend. The red lines connect the residues between which a cross-link has been formed.
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One monomethylated lysine residue (K385) was observed in
diphtheria toxoid (reaction 2). Such modiﬁcations were observed
previously in tetanus toxoid.17 This particular modiﬁcation cannot
be caused by treatment of formaldehyde alone because a mild
reducing agent is needed to convert a Schiff base into amonomethyl
group. Probably, formic acid used before LC-MS analyses might actas a reducing agent (Eschweiler74eClarke reaction). Therefore, this
modiﬁcation was not depicted in Figure 5.
Cross-Links
Seven unique peptides were identiﬁed that revealed
formaldehyde-induced cross-links (DM ¼ þ24 Da) between lysine
and arginine residues in diphtheria toxoid (Fig. 5). Furthermore, 8
ab
c
d
e
Figure 6. The intramolecular cross-link identiﬁed between A-fragment and B-fragment of diphtheria toxoid. LC/MS analyses performed on a chymotrypsin digest of diphtheria
toxoid prepared by reaction 2: (a) chromatographic separation of the cross-linked dipeptide, and (b) the observed mass spectral doublet. (c) MS2 analyses revealed the presence of a
cross-link between 2 peptides: (d) ETRGKRGQDAMY (712.0 Da) and (e) DVIRDKTKTKIESL (829.0 Da). The peptide sequences of D and E were identiﬁed by MS3 analysis.
B. Metz et al. / Journal of Pharmaceutical Sciences 109 (2020) 543-557550MS/MS spectra indicated cross-links between lysine and a second
amino acid residue, that is, a tyrosine and tryptophan residue.
However, these cross-links could not be conﬁrmed unambiguously
because Schiff bases cause the same mass increment as an intra-
molecular cross-link (DM ¼ þ12 Da). Therefore, the digested pep-
tides were treated with formaldehyde and NaCNBH3 to conﬁrm the
presence of an intramolecular cross-link between lysine and tyro-
sine or between lysine and tryptophan residues. This reactionresults in monomethylation of lysine residues in case of an intra-
molecular cross-link (DM ¼ þ12 Da (cross-link) þ14 Da (methyl
group) ¼ þ26 Da) and dimethylation in case of a Schiff base
(DM ¼ þ28 Da). The LC-MS analysis showed the existence of 3
intramolecular cross-links between a lysine and a tyrosine residue,
and one between a lysine and a tryptophan residue (Supplementary
Fig.1). In diphtheria toxoid, the formation of formaldehyde-induced
cross-links between the A-fragment and the B-fragment was
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Figure 7. Relative peak intensities of mass spectral singlets (blue) and doublets (red) of
peptides are presented and ranked in descending order. The singlets originate from
unmodiﬁed peptides, whereas doublets are formed by the treatment with light (CH2O)
and heavy (CD2O) formaldehyde. The relative peak intensities of peptides were
determined with LC-MS (between 105 and 1010 arbitrary units) after treatment of
diphtheria toxin with (a) formaldehyde (reaction 2), (b) formaldehyde and glycine after
dimethylation (reaction 3) or (c) formaldehyde and glycine (reaction 4) and after
digestion with chymotrypsin.
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amino acid residues that are likely to form these formaldehyde-
induced cross-links. Based on the crystal structure of diphtheria
toxin,72 reactive residuesof theA-fragment are in close proximityof
reactive residues in the B-fragment of diphtheria toxin, that is,
Lys172eArg210 and Arg190,192,193eSer194. The cross-link between
residues Lys172 and Arg210 was conﬁrmed by LC-MS (Fig. 6).
Contrarily, the presence of a cross-link between 1 of 3 arginine
residues (Arg190,192,193) and the N-terminal amino group of B-frag-
ment (Ser194) was not found.
Cross-links were formed effectively when the distance between
reactive residueswas between 4.6 and 10.7 Å (Supplementary Fig.1).
Within these distances, however, several other formaldehyde-induced cross-links could be expected, but were not identiﬁed.
However, incomplete protein coverage, low concentrations, or ioni-
zation intensities of these modiﬁed peptides or a poor peptide
fragmentation (CID or ETD), resulting in inconclusiveMS/MS spectra
could lead to overseeing cross-link identiﬁcations. As such, the
presence of expected cross-links cannot be ruled out.
Schiff-Bases
Nineteen peptides from diphtheria toxoid containing a Schiff-
base were identiﬁed. The Schiff-bases were located on 15 lysine
residues, 2 tryptophan residues and 1 histidine residue. Schiff-
bases were found despite bisulphite treatment and extensive
dialysis, performed to revert the reversible Schiff-bases and
methylol moieties in diphtheria toxoid. The Schiff bases and
methylol groups were more stable than expected.
Methylol Groups
Data analysis revealed the presence of reversible 26 methylol
groups present in diphtheria toxoid (DM ¼ þ30 Da). The methylol
groups were located on 17 distinct asparagine, 6 glutamine, 4 his-
tidine, 2 lysine residues, and 1 tryptophan residue.
Next to formaldehyde-induced modiﬁcations, oxidation of
methionine and deamidation of asparagine residues were observed
by LC-MS. However, the extent of oxidation and deamidation was
not increased on exposure to 37C for 7 days in reaction 2 (results
not shown).
After formaldehyde treatment, the reactive residues in diph-
theria toxoid are only partially converted. To get an impressionof the
degree of modiﬁcations, the intensities of the mass spectral singlets
and doublets detected by LC-MS were plotted independently in
descending order (Fig. 7a). The ﬁgure revealed that 17% of all hits
were mass spectral doublets, that is, 17% of the peptide hits con-
tained a formaldehyde-induced modiﬁcation. Furthermore, the in-
tensities of all singlets and doublets were added up, respectively.
Based on the total sumof intensities of the singlets and the doublets,
an average conversion by formaldehyde was calculated (Ʃ in-
tensities of doublets/Ʃ intensities of singlets þ doublets). The
average conversion of the amino acid residues in diphtheria toxoid
by reaction 2 was 11.6%.
In conclusion, the formaldehyde-treatment (reaction 2) resulted
in 5 different types of modiﬁcations, including intramolecular
cross-links in diphtheria toxoid.
Formaldehyde-Glycine Attachments in Diphtheria Toxoid
Diphtheria toxin was treated with formaldehyde and NaCNBH3
(to prevent intramolecular cross-linking) and subsequently with
formaldehyde (CH2O) and glycine or with deuterium-labeled
formaldehyde (CD2O) and glycine to introduce formaldehyde-
glycine attachments to receptive amino acid residues, that is,
arginine, asparagine, glutamine, histidine, tryptophan, or tyrosine
(reaction 3). Reaction 3 was performed to simplify the assignment
of formaldehyde-glycine attachments.
Diphtheria toxoid with only formaldehyde-glycine attachments
(reaction 3) revealed that the A-fragment and B-fragment of
diphtheria toxoid had an apparently increased mass when
compared to the untreated diphtheria toxin (Fig. 3; lane 3 vs. lane 0,
respectively). Moreover, SDS-PAGE revealed that the protein bands
were somewhat broadened as compared to those of diphtheria
toxin (lane 0), especially the bands of the A-fragment and appar-
ently intact diphtheria toxoid. This is probably due to the incor-
poration of different numbers of formaldehyde-glycine moieties in
diphtheria toxoid molecules.
In addition, the average number of primary amino groups in
diphtheria toxoid was considerably reduced (down to 8% relative to
Figure 8. The modiﬁcations in diphtheria toxin caused by formaldehyde-glycine treatment after dimethylation of lysine residues (reaction 3). (a) indicates the A fragment and (b)
the B fragment of diphtheria toxin. The blue line (y-axis left) indicates the theoretical solvent accessible surface area (accessibility) calculated using the molecular solvent radius of
the formaldehyde-glycine Schiff base after dimethylation of the 1TOX crystal structure. The modiﬁed and unmodiﬁed peptides derived from chymotrypsin digestion are indicated
with a solid and dotted dark red line, respectively, of which the intensities are plotted (y-axis right). In the case of overlapping peptides, the intensities are summed for the
overlapping amino-acid positions. The primary structure is indicated on the x-axis along with the amino acid position number in increments of 10 residues at the top of each plot.
The different amino acid modiﬁcations identiﬁed by MS analysis along with the secondary structure elements derived from the crystal structure PDB 1TOX. The catalytic site,
receptor binding site and CD4þ T-cell epitope are indicated with purple, black, and green underlines, respectively. The speciﬁc symbols are present in the ﬁgure legend.
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3). The TNBS assay revealed the presence of 2 remaining primary
amino groups on average in a diphtheria toxoid molecule. The
number of amino groups detected in diphtheria toxoid (reaction 3)
was comparable with the number of primary amino groups after
dimethylation (reaction 1).
Furthermore, LC-MS analysis of the chymotrypsin-digested
product of reaction 3 gave a protein coverage of 88% (72% of A-
fragment and 96% of B-fragment). The analysis revealed 156 pep-
tides with formaldehyde-glycine attachments (Supplementary
Table 4). These formaldehyde-modiﬁed peptides were recognizedby their mass spectral doublets by the use of CH2O and CD2O. Se-
quences of these modiﬁed peptides were assigned and several
peptides were detected with multiple modiﬁcations. The modiﬁ-
cations were identiﬁed byMS/MS analysis or allocated based on the
observed masses and the number of incorporated formaldehyde
molecules. Based on MS/MS analysis, 52 residues in diphtheria
toxoid were identiﬁed containing a formaldehyde-glycine attach-
ment (Fig. 8). Most of the moieties were attached to arginine and
tyrosine residues, but also modiﬁcations of asparagine, glutamine,
histidine, and tryptophan residues were observed. In theory, 103 of
535 amino acid residues in dimethylated diphtheria toxoid (reaction
B. Metz et al. / Journal of Pharmaceutical Sciences 109 (2020) 543-557 5533) can react with formaldehyde and glycine. However, arginine and
tyrosine residues can attach 2 formaldehyde-glycine moieties.55
Therefore, 137 formaldehyde-glycine moieties can be attached to
one dimethylated diphtheria toxoid molecule. In addition to
formaldehyde-glycine attachments, methylol groups and Schiff
bases were observed on particular amino acid residues, that is, on
asparagine, glutamine, histidine, and tryptophan residues.
To get an impression of the conversion of reactive residues by
formaldehyde and glycine (reaction 3), the intensities of the
modiﬁed (mass spectral doublets) and nonmodiﬁed peptides (mass
spectral singlets) were plotted separately in descending order
(Fig. 7b). The intensities of doublets relative to singlets give an
impression on the conversion of the reactive amino acid residues in
diphtheria toxoid molecules by formaldehyde and glycine. It
revealed that 30% of all hits were mass spectral doublets, demon-
strating the presence of a formaldehyde-induced modiﬁcation in
the peptide. The observations indicate that the average conversion
of amino acid residues by formaldehyde and glycine was 21.6% (Ʃ
intensities of doublets/Ʃ intensities of singlets þ doublets).
The conversion of individual reactive residues in diphtheria
toxoid by formaldehyde and glycine (reaction 3) depends on mul-
tiple factors, for example, concentrations of reagents (diphtheria
toxin, formaldehyde, glycine), reaction time, and pH. Moreover, the
intrinsic reactivity and accessibility of residues in diphtheria toxin
probably determine the conversion degree. The reactivity depends
on the type of amino acid residue, as demonstrated before.55 The
present study revealed that several rather inaccessible but reactive
residues (<25% accessible) contained formaldehyde/glycine-
induced modiﬁcations (Fig. 8). The accessibility of the modiﬁed
residues was calculated based on the crystal structure of diphtheria
toxin.67 Unexpectedly, no relationship (R2 ¼ 0.11) was observed
between the conversion of a particular type of residue (i.e., arginine
and tyrosine) and its accessibility (Supplementary Fig. 2).
Contrarily, the results of the present study do not match our pre-
vious study with insulin in which the conversion by formaldehyde
and glycine was depending on the accessibility.56 However, the
correlation “conversion versus accessibility” was based on only 4
tyrosine residues present in insulin.
In conclusion, glycine molecules were attached to diphtheria
toxin by formaldehyde. Most formaldehyde-glycine attachments
were located on the arginine and tyrosine residues in diphtheria
toxoid, irrespective of their position in the molecule.Detoxiﬁcation of Diphtheria Toxin by Formaldehyde and Glycine
The detoxiﬁcation of diphtheria toxin with a mixture of form-
aldehyde and glycine resulted in a very heterogeneous toxoid (re-
action 4). The heterogeneity of diphtheria toxoid could be
visualized by SDS-PAGE (Fig. 3; lane 4), showing 3 broadened
protein bands as compared to those of diphtheria toxin (lane 0),
corresponding to the entire diphtheria toxoid (approximate mo-
lecular weight of 58 kDa), A-fragment (22 kDa), and B-fragment (37
kDa). After chemical treatment (reaction 4), the intensity of the
apparent intact diphtheria toxoid band was increased when
compared to diphtheria toxin (lane 0). The broadened protein
bands were probably caused by intramolecular cross-links, as was
shown for formaldehyde-treated diphtheria toxoid (reaction 2) by
SDS-PAGE (Fig. 3; lane 2). Moreover, different numbers of
formaldehyde-glycine moieties (i.e., intermolecular cross-links)
may have been attached to diphtheria toxin molecules as well,
which might have contributed to the broadening of the protein
bands. In addition, the TNBS assay showed 75% reduction in the
number of primary amino groups, with on average only 7 primary
amino groups per toxoid molecule.Multiple formaldehyde-induced modiﬁcations (reaction 4) in
diphtheria toxoid were determined by using LC-MS analysis
(Supplementary Table 5). The chemical nature and the location of
formaldehyde/glycine-induced modiﬁcations were identiﬁed in
diphtheria toxoid (Fig. 9).
The stable formaldehyde-induced modiﬁcations could be
divided into intramolecular cross-links (reaction 2) and glycine
attachments (reaction 3). Moreover, reversible methylol groups and
Schiff bases were identiﬁed. LC-MS analysis provided a protein
coverage of 92% (86% of A-fragment and 95% of B-fragment).
We focused predominantly on the formaldehyde-induced
modiﬁcations in 3 areas of diphtheria toxin which are important
for its toxicity and immunogenicity: (1) the NADþ-binding cavity in
the catalytic domain, (2) the loop in the receptor domain involved
in receptor binding, and (3) T-cell epitopes. Chemical modiﬁcations
in the NADþ-binding cavity and receptor binding site contribute to
complete detoxiﬁcation of the diphtheria toxin. However, other
modiﬁcations might contribute to the reduction of toxicity as well,
for example, owing to conformational changes and cross-linking of
A-fragment and B-fragment.
Catalytic Site
The NADþ-binding cavity of the diphtheria toxin molecule con-
sists of 3 short peptide sequences which are folded together (resi-
dues: 17-23, 50-67, and 147-150). In theory, 10 amino acid residues
of the NADþ-binding cavity are reactivewith formaldehyde alone or
with formaldehyde and glycine (Tyr20, His21, Trp50, Lys51, Tyr54,
Asn58, Lys59, Tyr60, Tyr65, Tyr149). Amino acid residues His21, Tyr54,
and Tyr65 are involved in the binding of NADþ (Fig. 1). Three
formaldehyde-glycine attachmentswere found on tyrosine residues
(Tyr54, Tyr60, and Tyr149). The expected cross-link observed previ-
ously between residues Lys59 and Tyr60 (in reaction 3) was not
identiﬁed after treatment with formaldehyde and glycine (reaction
4). Based on these data, we can conclude that formaldehyde-glycine
attachments are the most common modiﬁcations present in the
NADþ-binding cavity, which will contribute to the inhibition of
NADþ-binding by diphtheria toxin.
Receptor-Binding Site
A second location studied in more detail for formaldehyde-
induced modiﬁcations was the receptor-binding site of diphtheria
toxin. With LC-MS analyses, modiﬁcations were identiﬁed at the
receptor-binding site of diphtheria toxin (Fig. 9). The peptides
contain an intramolecular cross-link between Lys516 and Tyr514.
Furthermore, formaldehyde-glycine attachments were formed at
amino acid residues Tyr514, His520 and Asn524. For residues Tyr514
and Asn524, participation in receptor binding has been demon-
strated.60 Moreover, residue Lys522 was cross-linked by formalde-
hyde to another residue (e.g., Tyr514 and His520) in the peptide
(Gly513eLeu527) based on themass increment of 12 Da found on this
lysine residue.
T-Cell Epitopes
Diphtheria toxoid contains 3 CD4þ T-cell epitopes which are
recognized by 70%-82% of the diphtheria-vaccinated humans.63 All
CD4þ T-cell epitopes are located in the B-fragment of diphtheria
toxin residues 271-290, 321-340, and 331-350, with 2 overlapping
epitopes. Several formaldehyde/glycine-induced modiﬁcations
were found in epitope 271-290 and epitope 321-340. However, the
epitope 331-350 contains only one reactive residue (Gln331). A
formaldehyde-glycine attachment to this glutamine residue
occurred, but in the vast majority of the diphtheria toxoid mole-
cules this epitope remained unchanged (Fig. 9). The latter is prob-
ably important for vaccine potency, as this particular epitope is
recognized by 82% of the human population (n ¼ 100).63
Figure 9. The modiﬁcations in diphtheria toxin caused by formaldehyde-glycine treatment (reaction 4). (a) indicates the A fragment and (b) the B fragment of diphtheria toxin. The
blue line (y-axis left) indicates the theoretical solvent accessible surface area (accessibility) calculated using the molecular solvent radius of the Schiff base of formaldehyde and
glycine. The modiﬁed and unmodiﬁed peptides derived from chymotrypsin digestion are indicated with a solid and dotted dark red line, respectively, of which the intensities are
plotted (y-axis right). In the case of overlapping peptides, the intensities are summed for the overlapping amino-acid positions. The primary structure is indicated on the x-axis
along with the amino acid position number in increments of 10 residues at the top of each plot. The different amino acid modiﬁcations identiﬁed by MS analysis along with the
secondary structure elements derived from the crystal structure PDB 1TOX. The catalytic site, receptor binding site, and CD4þ T-cell epitope are indicated with purple, black, and
green underlines, respectively. The speciﬁc symbols are present in the ﬁgure legend. The red lines are connecting the residues between which a cross-link has been formed.
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diphtheria toxoid, induced by formaldehyde and glycine (reaction
4), is difﬁcult to determine. An impression is given bycomparing the
intensities of the mass spectral doublets with the mass spectral
singlets (Fig. 7c). The study revealed that 17% of the peptides con-
tained formaldehyde-inducedmodiﬁcations. An average conversion
of amino acid residues in diphtheria toxoid by formaldehyde and
glycine (reaction 4) was calculated based on the total sum ofintensities of the singlets and the doublets (Ʃ intensities of doublets/
Ʃ intensities of singlets þ doublets). The average conversion of the
amino acid residues in diphtheria toxoid was 6.2%. The average
conversion by a standard detoxiﬁcation reaction (reaction 4) was
less than with the other 2 reaction conditions (reactions 2 and 3).
Based on these data, we conclude that both the NADþ-binding
cavity and the receptor-binding site are affected by intramolecular
cross-links or by formaldehyde-glycine attachments during the
Figure 10. Illustration of formaldehyde/glycine-induced modiﬁcations on diphtheria
toxin (PDB 1TOX). Amino acid residues that have cross-links being conﬁrmed by mass
spectrometric analysis are colored red (Lys), green (Arg), yellow (Tyr), and pink (Trp).
Formylation-glycine modiﬁcations on tryptophan and tyrosine are colored orange. Meth-
ylol, Schiff base, or formaldehyde-glycine modiﬁcations on His, Gln, and Asn are colored
cyan. Formylation-glycine modiﬁcations on Arg are colored green. Nonmodiﬁed amino
acids are colored black. Pymol v2.1.1 (Schrodinger LLC) was used to create this illustration.
B. Metz et al. / Journal of Pharmaceutical Sciences 109 (2020) 543-557 555standard detoxiﬁcation reaction (reaction 4). A combination of
formaldehyde-induced modiﬁcations in diphtheria toxoid will
ensure complete detoxiﬁcation of each toxoid molecule. Despite
the many modiﬁcations in several CD4þ T-cell epitopes, one majorTable 1
Expected Formaldehyde-Induced Cross-Links in Diphtheria Toxin
Position Sequence
KeR cross-links
K90eR133 KVLALKVDNAETIKKELGLSLTEPLMEQVGTEEFIKRFGDGASR
K125eR126 KR
R170eK172 RGK
K172eR173 KR
K172eR210 KRGQDAMYEYMAQACAGNRVRRSVGSSLSCINLDWDVIR
R210eK214 RDKTK
R407eK534 RTGFQGESGHDIKITAENTPLPIAGVLLPTIPGKLDVNKSKTHI
SVNGRKIRMRCRAIDGDVTFCRPKSPVYVGNGVHANLHV
AFHRSSSEKIHSNEISSDSIGVLGYQKTVDHTKVNSKLSLFFEIK
K440eR493 KLDVNKSKTHISVNGRKIRMRCRAIDGDVTFCRPKSPVY
VGNGVHANLHVAFHR
K445eR462 KSKTHISVNGRKIRMRCR
R493eK498 RSSSEK
KeY cross-links
K24eY27 KPGY
K24eY65 KPGYVDSIQKGIQKPKSGTQGNYDDDWKGFYST
DNKYDAAGY
K51eY54 KGFY
K59eY60 KY
K59eY181 KYDAAGYSVDNENPLSGKAGGVVKVTYPGLTKVLAL
KVDNAETIKKELGLSLTEPLMEQVGTEEFIKRFGDGAS
RVVLSLPFAEGSSSVEYINNWEQAKALSVELEINFE
TRGKRGQDAMYEY
K214eY358 KTKIESLKEHGPIKNKMSESPNKTVSEEKAKQYLEEFHQT
ALEHPELSELKTVTGTNPVFAGANYAAWAVNVAQVID
SETADNLEKTTAALSILPGIGSVMGIADGAVHHNTEEIV
AQSIALSSLMVAQAIPLVGELVDIGFAAY
Y380eK385 YSPGHK
Y514eK516 YQK
KeW cross-links
W153eK157 WEQAK
a Distance measured from Nε atom on Lys to one or more N atoms of the guanidine gr
b Distance measured between the a-carbon atoms between 2 cross-linked residues.epitope (at residue numbers 321-340) remained largely unmodi-
ﬁed (Fig. 10).Concluding Remarks
The formaldehyde-induced modiﬁcations in diphtheria toxoid
were investigated with a detailed analysis of the NADþ-binding
cavity and receptor-binding site. In both areas of the toxoid mole-
cule, intramolecular cross-links and formaldehyde-glycine attach-
ments were found. Moreover, cross-links occurred between the A-
fragment and B-fragment of diphtheria toxoid. The conversion of
these sites contributes to the inactivation of diphtheria toxin
(Fig. 10).
The study revealed that all primary amino groups in diphtheria
toxin are accessible to formaldehyde (demonstrated by reaction 1).
Only 11 of 39 lysine residues formed formaldehyde-induced intra-
molecular cross-links with neighboring amino acid residues (reac-
tion 2). The formaldehyde-induced intramolecular cross-links
(Table 1) were formed between residues in close proximity of each
other (distances of a-carbon atoms 3.8-10.9 Å). However, several
other intramolecular cross-links that were expected, according to
the crystal structure of diphtheria toxin, could not be conﬁrmed.
Possibly, these cross-links were not constructed because these res-
idues are very mobile in solution or because their orientation is
incompatible with cross-linking. In addition to intramolecular
cross-links, formaldehyde- and glycine-inducedmodiﬁcationswere
introduced during the detoxiﬁcation reaction by formaldehyde and
glycine. The modiﬁcations are most frequently found on arginine
and tyrosine residues. Remarkably, relatively inaccessible but
reactive residues were also modiﬁed by formaldehyde and glycine.
In a fewparticular cases, the conversion of inaccessible residueswas
rather high (above 50%; Fig. 10). Unlike our expectation, theDistance Reactive Sites (Å)a a-Carbon Distance (Å)b Identiﬁed
13.2 6.1 no
10.7 3.8 yes
8.9 5.6 yes
6.8 3.8 yes
7.5 10.9 yes
7.0 6.6 no
6.7 4.8 yes
10.7 5.5 no
5.3 9.0 no
12.7 9.7 yes
8.6, 10.4 5.8 yes
7.1, 8.4 7.5 no
10.0, 12.0 9.2 no
4.6, 5.3 3.8 yes
5.5, 6.6 9.4 no
6.5, 8.5 10.0 no
5.7, 6.7 7.0 no
4.6, 6.0 6.5 yes
10.6 6.8 yes
oup on Arg, meta C-H bond on Tyr, or to N atom on the indol group of Trp.
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dues. Probably, the formaldehyde-glycine moieties could reach
rather inaccessible residues due to conformational dynamicswithin
the diphtheria toxin molecule.
The detoxiﬁcation process changes the antigenicity and immu-
nogenicity of diphtheria toxoid.16 The formaldehyde-induced
modiﬁcations located on or near the immunodominant B-cell and
T-cell epitopes of diphtheria toxin are of special interest. These
modiﬁcations might affect the antigenicity and immunogenicity
signiﬁcantly. The immunodominant CD4þ T-cell epitopes have been
identiﬁed and examined.63 Our study revealed that one dominant
CD4þ T-cell epitope remained almost completely unaltered on
formaldehyde-glycine treatment. This particular epitope is recog-
nized by 82% of the subjects (n ¼ 100). Unfortunately, the immu-
nodominant B-cell epitopes are unknown. Our previous study
revealed that formaldehyde treatment results in the impairment of
particular B-cell epitopes in diphtheria toxin. The impairment was
measured by biosensor analysis using a set of monoclonal anti-
bodies.16 Therefore, formaldehyde-induced modiﬁcations in these
immunodominant B-cell epitopes cannot be excluded. A different
detoxiﬁcation matrix might result in a distinct antigenicity and
immunogenicity. Therefore, the detoxiﬁcation process could deter-
mine the efﬁcacy of the diphtheria vaccine in humans considerably.
The strategy followed in this study was suitable to identify the
different types of formaldehyde-induced modiﬁcations in diph-
theria toxoid. However, in many vaccine production processes of
diphtheria toxoid, the detoxiﬁcation of diphtheria toxin takes place
in a matrix of culture supernatant with various amino acid com-
positions. The attachments of different amino acids to the reactive
residues of diphtheria toxin will add to the heterogeneity of the
resulting toxoid. The identiﬁcation of modiﬁed residues in such a
diphtheria toxoid can be very difﬁcult and laborious, even with the
sophisticated mass spectrometers and software tools available
today. Nevertheless, the methods can be used to analyze such
products in comparability studies, for example, to support regis-
tration of these products after process or formulation improve-
ments. The work demonstrates that with current powerful
analytical techniques, it is possible to approach classical vaccines as
if they were well-deﬁned biologicals.
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